RAPT Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
46.90
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
6
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.67
|
-0.63
|
0.04
|
5.97%
|
|
2022-06-30
|
-0.75
|
-0.62
|
0.13
|
17.33%
|
|
2022-03-31
|
-0.68
|
-0.69
|
-0.01
|
-1.47%
|
|
2021-12-31
|
-0.66
|
-0.61
|
0.05
|
7.58%
|
|
2021-09-30
|
-0.62
|
-0.63
|
-0.01
|
-1.61%
|
|
2021-06-30
|
-0.67
|
-0.63
|
0.04
|
5.97%
|
|
2021-03-31
|
-0.62
|
-0.66
|
-0.04
|
-6.45%
|
|
2020-12-31
|
-0.59
|
-0.52
|
0.07
|
11.86%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.94
|
|
2021-12-31
|
-2.53
|
|
2020-12-31
|
-2.19
|
|
2019-12-31
|
-13.59
|